InVivo Therapeutics Holdings Corporation
OTC: NVIVQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard M. Toselli
- Employees
- 6
- Headquarters
- Cambridge, United States
- IPO year
- 2010
- Market cap
- $1.1M
- Website
- https://www.invivotherapeutics.com
Loading NVIVQ…
Loading profile data…Frequently asked questions about NVIVQ
What does InVivo Therapeutics Holdings Corporation (NVIVQ) do?
InVivo Therapeutics Holdings Corp. is a U.S.-based biotechnology and biomaterials company, engaged in both research and clinical development. The company's primary focus is on pioneering and commercializing biopolymer scaffolding devices specifically designed for the treatment of spinal cord injuries (SCI). Its flagship product under development...
Where does NVIVQ trade?
InVivo Therapeutics Holdings Corporation (NVIVQ) trades on the Other OTC.
What sector is NVIVQ in?
InVivo Therapeutics Holdings Corporation (NVIVQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of InVivo Therapeutics Holdings Corporation?
Richard M. Toselli is the chief executive officer of InVivo Therapeutics Holdings Corporation (NVIVQ).
Where is InVivo Therapeutics Holdings Corporation headquartered?
InVivo Therapeutics Holdings Corporation is headquartered in United States.
Does NVIVQ pay a dividend?
InVivo Therapeutics Holdings Corporation (NVIVQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVIVQ go public?
InVivo Therapeutics Holdings Corporation (NVIVQ) completed its initial public offering in 2010.